US

Uttam Samanta

Active Director Director DIN 09620529
DIN 09620529 First appointment May 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value •••• Premium profile

About Uttam Samanta

Data last updated:

Uttam Samanta is a Director at Akiums Pharma Private Limited (since 2022). The company operates in Chemicals. Akiums Pharma Private Limited reported revenue of ₹7.2 Lakh (FY 2024).

DIN 09620529
Primary Designation Director
Industry Chemicals
First Appointment 26 May 2022
Oldest Company Age 4 yrs
Largest company Akiums Pharma Private Limited · ₹7.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Akiums Pharma Private Limited U24100WB2022PTC254260
Director26 May 20222022₹7.2 Lakh (FY 2024)Active

Board colleagues of Uttam Samanta

NameDINCompanyDesignation
Mithu Samanta09620530Akiums Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Akiums Pharma Private Limited
Premium access

Shareholding and investment profile for Uttam Samanta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Uttam Samanta

Uttam Samanta currently holds 1 directorship: Akiums Pharma Private Limited (Director, since 26 May 2022, revenue ₹7.2 Lakh (FY 2024)).

Uttam Samanta was first appointed on 26 May 2022 as Director at Akiums Pharma Private Limited.

The current boards of Uttam Samanta's companies include Mithu Samanta (Akiums Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available